Medtronic

MEDTRONIC NEWSROOM (16 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2025 2024 2023 2018 2017 2016 2015 2014

Medtronic plc announces leadership changes

PRESS RELEASE -- 20, December 2017

Bryan Hanson Leaves Medtronic to Become President and CEO of a Public Company DUBLIN, 20-Dec-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic’s Asia Pacific (APAC) Region, has been … Read the full press release

Medtronic announces U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology

PRESS RELEASE -- 21, November 2017

Azure(TM) with BlueSync(TM) Technology Improves Device Longevity  and Provides Automatic, Wireless Remote Patient Monitoring DUBLIN, 21-Nov-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers … Read the full press release

Medtronic plc and American Well® to enable patient access to American Well’s telemedicine services on MCMS’ video-enabled platforms

PRESS RELEASE -- 17, October 2017

Partnership Focused on Enabling Care for Chronic, Co-Morbid Patients DUBLIN and BOSTON, MA, U.S.A., 17-Oct-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business and American Well® entered into a first-of-its-kind strategic partnership to enable … Read the full press release

Medtronic to open Innovation Center at the Singapore-Sichuan Hi-Tech Innovation Park

PRESS RELEASE -- 11, October 2017

Facilitating Clinical Training for Physicians and Advancing Local Healthcare Efficiency in Central and Western China DUBLIN, Ireland and CHENGDU, Sichuan, 11-Oct-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced the groundbreaking of its Chengdu Innovation Center at the Singapore-Sichuan Hi-Tech Innovation … Read the full press release

Medtronic: U.S. FDA approval for the Endurant(TM) II/IIs stent graft system

PRESS RELEASE -- 11, October 2017

New Indication Expands Treatment Options for AAA Patients with Hostile Neck Anatomy DUBLIN, 11-Oct-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the Endurant(TM) II/IIs stent graft … Read the full press release

High blood pressure: Medtronic to move forward with a new renal denervation pivotal trial

PRESS RELEASE -- 4, September 2017

Published Simultaneously in The Lancet, the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure DUBLIN and BARCELONA, 04-Sep-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced its intent … Read the full press release

Medtronic: global randomized clinical trial to evaluate one-month dual antiplatelet therapy (DAPT) in patients with the Resolute Onyx(TM) DES during percutaneous coronary intervention (PCI)

PRESS RELEASE -- 18, August 2017

First-of-its-Kind Randomized Clinical Trial Will Evaluate One-Month DAPT in Patients Following PCI Procedures with the Newer-Generation Durable Polymer Resolute Onyx DES DUBLIN, 18-Aug-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced a global randomized clinical trial that will evaluate one-month … Read the full press release

Medtronic: treating paroxysmal atrial fibrillation with cryoballoon catheter ablation results in cost savings as compared to radiofrequency ablation

PRESS RELEASE -- 3, August 2017

Data from Landmark Trial Published in the Journal of the American Heart Association DUBLIN, 03-Aug-2017 — /EuropaWire/ — A new health economic analysis from the landmark FIRE AND ICE Trial, sponsored by Medtronic plc (NYSE: MDT), was published today in the Journal of … Read the full press release

European launch of Medtronic CoreValve(TM)Evolut(TM) PRO valve for the treatment of severe aortic stenosis

PRESS RELEASE -- 3, August 2017

DUBLIN, 03-Aug-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced CE (Conformité Européenne) mark and European launch of the CoreValve(TM)Evolut(TM) PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at intermediate, high or extreme risk … Read the full press release

Track Patient Health at Home with Synchronization of Garmin Activity Tracker Data and Medtronic Mobile Application

PRESS RELEASE -- 21, April 2017

Data from Garmin vívofit® Series Now Syncs to Medtronic Care Management Services NetResponse® Mobile Application to Help Track Patient Health at Home DUBLIN and OLATHE, Kan. U.S.A., 21-Apr-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, and … Read the full press release

Study Showcases Economic Value of Earlier Patient Access to Medtronic Cardiac Resynchronization Therapy Devices

PRESS RELEASE -- 28, February 2017

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced an economic analysis of five-year data showing that patients with mild heart failure who get cardiac resynchronization therapy (CRT) devices early in their treatment live longer and that implanting these devices … Read the full press release

Medtronic to present at the 37th Annual Cowen and Company Healthcare Conference on March 7, 2017

PRESS RELEASE -- 28, February 2017

DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc  (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual Cowen and Company Healthcare Conference on Tuesday, March 7, 2017, in Boston, Mass. Geoff Martha, executive vice president … Read the full press release

Medtronic receives CE (Conformité Européenne) Mark for its suite of quadripolar cardiac resynchronization therapy pacemakers

PRESS RELEASE -- 28, February 2017

Suite of Smart Heart Failure Devices Offers More-Effective Pacing, Expanded MRI Access DUBLIN, 28-Feb-2017 — /EuropaWire/ — Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for a suite of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) that … Read the full press release

Medtronic presents results supporting the IN.PACT® Admiral® drug-coated balloon in patients with peripheral arterial disease

PRESS RELEASE -- 25, January 2017

First Presentation of Results from Regional Cohorts of IN.PACT Global Study Reinforce Strong, Consistent and Safe Outcomes for PAD Patients  DUBLIN and LEIPZIG, 25-Jan-2017 — /EuropaWire/ — Medtronic today presented new data at the Leipzig Interventional Course (LINC) 2017 conference supporting … Read the full press release

Medtronic expands directional atherectomy portfolio in Europe with new 6F HawkOne

PRESS RELEASE -- 25, January 2017

Expands Treatment Options for Patients in Europe with Peripheral Artery Disease Both Above and Below the Knee DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) today announced CE (Conformité Européene) Mark approval for the HawkOne(TM) directional atherectomy system in a … Read the full press release

Medtronic announces first procedure using Visualase(TM) MRI-Guided Laser Ablation System for treatment of common form of epilepsy

PRESS RELEASE -- 25, January 2017

DUBLIN, 25-Jan-2017 — /EuropaWire/ — Medtronic plc (NYSE: MDT) announced today that the first procedure using the Visualase(TM) MRI-Guided Laser Ablation System has been performed in the pivotal SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) clinical trial at Mayo Clinic … Read the full press release